CAI Caris Life Sciences, Inc.

NASDAQ
$28.35

Caris Life Sciences, Inc. (CAI) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with CAI's own trailing one-year pace, with 6% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
4
4 transactions
Insiders selling
4
7 transactions
Purchases
$1.6M
103,634 shares
Sales
$28.9M
1,066,962 shares
Net activity
-$27.3M
purchases less sales

How much of that selling was preplanned? 6% planned / 94% discretionary

10b5-1 plan sales $1.7M 2 transactions · 62,250 shares
Discretionary sales $27.2M 5 transactions · 1,004,712 shares

Largest single sale: $12.1M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: May 15, 2026 , by HALBERT JON .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Denton John Russel See Remarks Sell 7,500 $31.82 $238.6K 174,855 −4.1% of holding
Brille Brian J See Remarks Sell 400,000 $30.33 $12.1M 230,303 −63.5% of holding
Spetzler David Baxley President Sell 119,212 $24.76 $3.0M 1,182,871 −9.2% of holding
Spetzler David Baxley 2 fills President Sell 478,000 $24.86 $11.9M 1,136,983 −29.6% of holding
HALBERT JON Director Buy 68,000 $14.56 $990.1K 704,598
Vacirca Jeff L Director Buy 31,050 $16.15 $501.4K 49,671
Power Luke Thomas 2 fills See Remarks Sell 10b5-1 62,250 $26.58 $1.7M 100,971 −38.1% of holding
Denton John Russel See Remarks Buy 4,184 $24.09 $100.8K 9,184
Spetzler David Baxley President Buy 400 $23.85 $9.5K 460,777

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.